Arcadia Biosciences, Inc. (RKDA) Net margin 2017–2025
Arcadia Biosciences, Inc. (RKDA) net profit margin by fiscal year — reported net income divided by reported revenue.
-48.1%FY2025 · since FY2017: -390.1% → -48.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -48.1% | +91.4 pp |
| FY2024 | -139.5% | +174.4 pp |
| FY2023 | -313.9% | -106.6 pp |
| FY2022 | -207.3% | +8.9 pp |
| FY2021 | -216.2% | -158.3 pp |
| FY2020 | -57.9% | +2406.1 pp |
| FY2019 | -2464.1% | -1543.3 pp |
| FY2018 | -920.8% | -530.6 pp |
| FY2017 | -390.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice